Posts

Showing posts from April 5, 2009

Intro: International Stem Cell Corporation (ISCO.OB)

Image
International Stem Cell Corporation (ISCO.OB) is a California company that has developed breakthrough human stem cell lines that promise to eliminate the rejection of transplanted cells by the patient’s immune system. ISCO’s technology, Parthenogenesis, results in the creation of pluripotent human stem cell lines from unfertilized human eggs without the transfer of foreign DNA. This methodology offers the potential to create the first true “Stem Cell Bank” and also addresses critical ethical issues by eliminating the need to use fertilized embryos. ISCO also produces and sells specialized cells and growth media worldwide for therapeutic research.
...

...

International Stem Cell Research - The best bloopers are a click away

Webinar: Stem Cell Advancement Beyond Embryonic Cell Use

Image
In cell biology, the definition of pluripotency has come to refer to a stem cell that has the potential to differentiate into any of the three germ layers: endoderm (interior stomach lining, gastrointestinal tract, the lungs), mesoderm (muscle, bone, blood, urogenital), or ectoderm (epidermal tissues and nervous system). Pluripotent stem cells can give rise to any fetal or adult cell type. However, alone they cannot develop into a fetal or adult animal because they lack the potential to contribute to extraembryonic tissue, such as the placenta.In contrast to pluripotent stemcells, many progenitor cells are multipotent, i.e. they are capable of differentiating into a limited number of tissue types.
...


...

Privacy Notice

Privacy Notice: The sites and blogs of ALTACITIES conform to these PRIVACY PRACTICES.